Transmedics Group, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.06% of TransMedics Group Inc.'s common stock as of March 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 1,949,420 shares, representing 5.68% of TransMedics Group Inc.'s common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amendment to its Schedule 13G, reporting 0% beneficial ownership in TransMedics Group Inc. following an internal realignment.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 14.6% in TransMedics Group, Inc., totaling 4,955,262 shares of common stock.
NASDAQ
FMR LLC and its affiliates, along with Abigail P. Johnson, have disclosed a significant 15.0% beneficial ownership stake in TransMedics Group Inc., as detailed in their latest Schedule 13G filing.